Ramya Lekha Medida
Papers
1
Total Citations
2
H-Index
1
About
Dr. Ramya Lekha Medida is a pioneering researcher in the field of advanced drug delivery systems, with a particular focus on oral biologics and robotic pill technologies. Her most cited work, a 2023 study published in the *Journal of the Endocrine Society*, demonstrates a proof-of-concept for a once-daily follicle stimulating hormone (FSH) biosimilar delivered via an orally ingestible robotic pill (RT-112). This research addresses a critical patient preference for non-injectable fertility treatments, potentially revolutionizing the administration of peptide hormones. With 2 citations to date, the study highlights her contributions to patient-centric design and the translation of robotic platforms from preclinical to clinical applications. Dr. Medida’s work at Rani Therapeutics has been instrumental in validating the safety and efficacy of the RT-112 device, which autonomously deploys a dissolvable microneedle array in the gastrointestinal tract to deliver macromolecules. Her findings not only offer a less invasive alternative for fertility patients but also pave the way for broader use of oral biologics in chronic disease management. As a rising voice in drug delivery innovation, Dr. Medida continues to bridge engineering and endocrinology, making her a key figure to watch in the evolution of smart pill therapeutics.
Research Focus
Key Achievements
Top Papers
- 1